These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24938018)

  • 1. Apolipoprotein B-48: a unique marker of chylomicron metabolism.
    Nakajima K; Nagamine T; Fujita MQ; Ai M; Tanaka A; Schaefer E
    Adv Clin Chem; 2014; 64():117-77. PubMed ID: 24938018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.
    Gianturco SH; Ramprasad MP; Song R; Li R; Brown ML; Bradley WA
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):968-76. PubMed ID: 9633939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial lipoprotein metabolism: VLDL vs chylomicrons.
    Nakajima K; Nakano T; Tokita Y; Nagamine T; Inazu A; Kobayashi J; Mabuchi H; Stanhope KL; Havel PJ; Okazaki M; Ai M; Tanaka A
    Clin Chim Acta; 2011 Jul; 412(15-16):1306-18. PubMed ID: 21531214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2007 Oct; 194(2):473-82. PubMed ID: 17045270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism.
    Hanada H; Mugii S; Okubo M; Maeda I; Kuwayama K; Hidaka Y; Kitazume-Taneike R; Yamashita T; Kawase R; Nakaoka H; Inagaki M; Yuasa-Kawase M; Nakatani K; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Nishida M; Komuro I; Yamashita S
    Clin Chim Acta; 2012 Jan; 413(1-2):160-5. PubMed ID: 21958700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.
    Karpe F; Bickerton AS; Hodson L; Fielding BA; Tan GD; Frayn KN
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):472-6. PubMed ID: 17511631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human intestinal lipoproteins. Studies in chyluric subjects.
    Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
    J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma.
    Nakano T; Tanaka A; Okazaki M; Tokita Y; Nagamine T; Nakajima K
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):57-64. PubMed ID: 21098545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases.
    Nakano T; Nakajima K; Niimi M; Fujita MQ; Nakajima Y; Takeichi S; Kinoshita M; Matsushima T; Teramoto T; Tanaka A
    Clin Chim Acta; 2008 Apr; 390(1-2):38-43. PubMed ID: 18206113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signposts in the assembly of chylomicrons.
    Hussain MM; Kedees MH; Singh K; Athar H; Jamali NZ
    Front Biosci; 2001 Mar; 6():D320-31. PubMed ID: 11229873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.
    Davidson NO; Shelness GS
    Annu Rev Nutr; 2000; 20():169-93. PubMed ID: 10940331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of plasma triglycerides in insulin resistance and diabetes.
    Ginsberg HN; Zhang YL; Hernandez-Ono A
    Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for measuring intestinal and hepatic triacylglycerol kinetics.
    Sun F; Stolinski M; Shojaee-Moradie F; Lou S; Ma Y; Hovorka R; Umpleby AM
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E1041-7. PubMed ID: 23592484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial hyperlipidemia and remnant lipoproteins.
    Havel RJ
    Curr Opin Lipidol; 1994 Apr; 5(2):102-9. PubMed ID: 8044412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of total plasma apolipoprotein B concentration in human subjects.
    Schonfeld G; Lees RS; George PK; Pfleger B
    J Clin Invest; 1974 May; 53(5):1458-67. PubMed ID: 4363408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
    Qin B; Dawson H; Anderson RA
    Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.